QXO Launches Hostile Takeover Bid for Beacon Building Products After Repeated Rejections Indian Stock Market Pine Labs RVNL Dip After Earnings LIC Campus Activewear Gain Investors Flock to HALO Stocks Betting on Assets AI Cannot Replace Ella Langley Achieves Historic Billboard Hot 100 Milestone for Country Music Oura Health Files Confidentially for IPO Smart Ring Maker Eyes Public Markets Oregons Gas Tax Rejection Could Reshape Infrastructure Funding and Senator Merkleys ReElection Path JELD Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions OTEX Q1 2026 Earnings EPS Beats Estimates by 746 Shares Edge Higher Bridgewater Bancshares Inc BWB Q1 2026 Earnings EPS Falls Short of Consensus by Narrow Margin ASUR Q1 2026 Earnings EPS Surprises to the Upside Despite Broader Market Headwinds CURI Q1 2026 Earnings EPS Miss Amid Subscriber Challenges Fortress Biotech Preferred Stock FBIOP Q4 2025 Earnings EPS Misses Estimates by Over 108 Canadian Natural Resources CNQ Faces Selling Pressure After Steep Decline Maplebear Inc CART Slips 124 as Shares Approach Key Support Level M3Brigade Acquisition VI Corp Warrant MBVIW Holds Steady at 040 Near Key Support Akebia Therapeutics AKBA Holds Steady at 102 as Support and Resistance Levels Tighten Bgin Blockchain BGIN Tests Support Zone Following Modest Decline AVGO Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Imperial Petroleum Inc 875 Series A Preferred Shares IMPPP Q1 2026 Earnings Strong Earnings Beat Highlights Operational Efficiency PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances Pearl Diver Credit Company Inc 800 Series A Preferred Stock Due 2029 PDPA Q4 2025 Earnings Preferred EPS Misses Estimates as Credit Market Headwinds Emerge TD SYNNEX SNX Q1 2026 Earnings Strong EPS Beat of 416 Overshadowed by Tepid Stock Response Lakeland Financial Corporation Q1 2026 Earnings EPS Slightly Beats Estimates Amidst Flat Revenue Environment Uber Stock Options Strategy Could Yield 44 Return in Rangebound Trading NESR Q1 2026 Earnings EPS Surprise of 1987 Beats Estimates Stock Slides 2 Acrivon Therapeutics ACRV Edges Higher Biotech Stock Tests Key Resistance at 177